Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RARE
RARE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RARE News
Ultragenyx Strategic Restructuring and Product Launch Outlook
1d ago
Benzinga
Ultragenyx Pharmaceutical Faces Class Action Lawsuit Over Securities Violations
35m ago
Globenewswire
Ultragenyx Pharmaceutical Class Action Update
1d ago
Businesswire
Class Action Lawsuit Reminder Against Ultragenyx Pharmaceutical Inc.
1d ago
Globenewswire
Ultragenyx Pharmaceutical Lowers Revenue Outlook Below Consensus
1d ago
seekingalpha
Ultragenyx Faces Regulatory Challenges from FDA Rejections
2d ago
stocktwits
Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.
2d ago
Globenewswire
Ultragenyx Faces Class Action Lawsuit Impact
2d ago
PRnewswire
Ultragenyx Reports Q4 Loss but Revenue Growth Amid Restructuring
2d ago
NASDAQ.COM
Ultragenyx Pharmaceutical Q4 Earnings Report Analysis
2d ago
seekingalpha
Ultragenyx Pharmaceutical Faces Securities Fraud Class Action Lawsuit
3d ago
PRnewswire
Ultragenyx Faces Class Action Over Misleading Drug Information
3d ago
Globenewswire
Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical
3d ago
PRnewswire
Ultragenyx Pharmaceutical Faces Securities Fraud Class Action Lawsuit
3d ago
Globenewswire
Ultragenyx Pharmaceutical Set to Announce Q4 Earnings on February 12
3d ago
seekingalpha
Ultragenyx Pharmaceutical Faces Class Action Lawsuit
4d ago
Globenewswire
Show More News
